SHUKRA PHARMACEUTICALS
Back to Income Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹33 Cr | ₹75 Cr | ₹59 Cr | ₹20 Cr | ₹11 Cr |
What is the latest Revenue of SHUKRA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹59 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹11 Cr |
How is Revenue of SHUKRA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | -56.30 | |
| Mar2024 | ₹75 Cr | 26.75 | |
| Mar2023 | ₹59 Cr | 187.19 | |
| Mar2022 | ₹20 Cr | 82.98 | |
| Mar2021 | ₹11 Cr | - | |
Compare Revenue of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,548.0 Cr | 1.5% | -11.8% | 73.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 1.5% |
-11.8% |
73.7% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses